BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 18625168)

  • 21. Correlation of prostate volume with international prostate symptom score and quality of life in men with benign prostatic hyperplasia.
    Agrawal CS; Chalise PR; Bhandari BB
    Nepal Med Coll J; 2008 Jun; 10(2):104-7. PubMed ID: 18828432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bothersome urinary symptoms and disease-specific quality of life in patients with benign prostatic obstruction.
    Marklund-Bau H; Edéll-Gustafsson U; Spångberg A
    Scand J Urol Nephrol; 2007; 41(1):32-41. PubMed ID: 17366100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation and treatment of lower urinary tract symptoms in older men.
    Abrams P; Chapple C; Khoury S; Roehrborn C; de la Rosette J;
    J Urol; 2009 Apr; 181(4):1779-87. PubMed ID: 19233402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment, diagnosis and management of lower urinary tract symptoms in men.
    Brown CT; Das G
    Int J Clin Pract; 2002 Oct; 56(8):591-603. PubMed ID: 12425369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between lower urinary tract symptoms and objective measures of benign prostatic hyperplasia: a Chinese survey.
    Wang JY; Liu M; Zhang YG; Zeng P; Ding Q; Huang J; He DL; Song B; Kong CZ; Pang J
    Chin Med J (Engl); 2008 Oct; 121(20):2042-5. PubMed ID: 19080272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changing aspects in the evaluation and treatment of patients with benign prostatic hyperplasia.
    Lam JS; Cooper KL; Kaplan SA
    Med Clin North Am; 2004 Mar; 88(2):281-308. PubMed ID: 15049579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Common questions about the diagnosis and management of benign prostatic hyperplasia.
    Pearson R; Williams PM
    Am Fam Physician; 2014 Dec; 90(11):769-74. PubMed ID: 25611711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical guideline for male lower urinary tract symptoms.
    Homma Y; Araki I; Igawa Y; Ozono S; Gotoh M; Yamanishi T; Yokoyama O; Yoshida M;
    Int J Urol; 2009 Oct; 16(10):775-90. PubMed ID: 19811547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [General practitioners' approach to urination disorders in men over the age of 50. A survey of 250 physicians in Brittany].
    Coeurdacier P; Staerman F; Thoquenne G; Cipolla B; Guillé F; Lobel B
    Prog Urol; 1996 Feb; 6(1):52-9. PubMed ID: 8624528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The role of the IPSS (International Prostate Symptoms Score) to evaluate the frequency of disability induced by each of the 7 symptoms. (CTMH-AFU study)].
    de la Taille A; Desgrandchamps F; Haillot O; Saussine C; Lukacs B; Marc F;
    Prog Urol; 2006 Nov; 16(5):568-71. PubMed ID: 17175953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Benign prostatic hyperplasia. Guidelines and recommendations in urological clinical practice].
    Silva MM; Sousa RC
    Acta Med Port; 1999; 12(1-3):103-11. PubMed ID: 10423883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Benign hypertrophy of the prostate].
    Descazeaud A; de La Taille A
    Rev Prat; 2006 Dec; 56(20):2283-9. PubMed ID: 17352329
    [No Abstract]   [Full Text] [Related]  

  • 33. Diagnosis and management of benign prostatic hyperplasia.
    Edwards JL
    Am Fam Physician; 2008 May; 77(10):1403-10. PubMed ID: 18533373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Adaptation and validation in the French language of the International Score of Symptoms of Benign Prostatic Hypertrophy].
    Sagnier PP; Richard F; Botto H; Teillac P; Dreyfus JP; Boyle P
    Prog Urol; 1994; 4(4):532-8; discussion 539-40. PubMed ID: 7522745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Swedish version of a quality of life questionnaire for partners of men with symptoms suggestive of benign prostatic obstruction.
    Marklund-Bau H; Edéll-Gustafsson U; Spångberg A
    Scand J Urol Nephrol; 2008; 42(2):126-31. PubMed ID: 18365923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New diagnostic and treatment guidelines for benign prostatic hyperplasia. Potential impact in the United States.
    Jacobsen SJ; Girman CJ; Guess HA; Oesterling JE; Lieber MM
    Arch Intern Med; 1995 Mar; 155(5):477-81. PubMed ID: 7532392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective comparison of a new visual prostate symptom score versus the international prostate symptom score in men with lower urinary tract symptoms.
    van der Walt CL; Heyns CF; Groeneveld AE; Edlin RS; van Vuuren SP
    Urology; 2011 Jul; 78(1):17-20. PubMed ID: 21550646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical guideline for benign prostatic hyperplasia].
    Gotoh M; Ono Y; Ohshima S
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():311-7. PubMed ID: 12599591
    [No Abstract]   [Full Text] [Related]  

  • 39. Benign prostatic hyperplasia: clinical manifestations and evaluation.
    Santos Dias J
    Tech Vasc Interv Radiol; 2012 Dec; 15(4):265-9. PubMed ID: 23244722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Benign prostatic hyperplasia; recommendations for transmural care. Working Group, Dutch College of General Practitioners and Netherlands College of Urologists].
    Klomp ML; Rosmalen CF; Romeijnders AC; Oosterhof GO; Schlatmann TJ
    Ned Tijdschr Geneeskd; 1998 Nov; 142(47):2563-8. PubMed ID: 10028352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.